Back to Menu
1. Active surveillance
For asymptomatic nonfunctioning microadenomas, periodic MRI and hormonal testing are performed to monitor growth and avoid unnecessary treatment-related risks.
2. Medical therapy
Dopamine agonists reduce prolactin levels and shrink prolactinomas; somatostatin analogs control hormone secretion in growth hormone–secreting adenomas.
3. Minimally invasive endoscopic endonasal transsphenoidal surgery
A mainstream approach that removes the tumor through a natural nasal corridor, with minimal trauma, high precision, and rapid recovery.
4. Craniotomy
For giant tumors or lesions with substantial suprasellar extension, transcranial approaches may be required to address complex anatomy, although they are relatively more invasive.
5. Stereotactic radiosurgery
For postoperative residual or recurrent disease, or for patients who are not surgical candidates, Gamma Knife–based high-precision irradiation can effectively control tumor growth.
6. Stepwise staged treatment
For giant invasive tumors, endoscopic debulking and decompression may be performed first, followed by craniotomy or radiotherapy, to preserve neurological function.
7. Pituitary hormone replacement therapy
If the tumor or treatment results in hypopituitarism, long-term hormone replacement is required to maintain normal metabolism.
8. Multidisciplinary collaborative care
Neurosurgery, endocrinology, and other specialties jointly determine management to ensure individualized and evidence-based treatment strategies.
Jinshazhou Hospital of Guangzhou University of Chinese Medicine emphasizes that although most pituitary adenomas are benign, they can cause substantial impairment of vision, fertility, and other functions. Standardized diagnosis is the first step toward effective management, and early intervention is fundamental to preventing irreversible damage. With MDT-based collaboration and minimally invasive techniques, treatment outcomes can be improved and patients can return to health.
1. Active surveillance
For asymptomatic nonfunctioning microadenomas, periodic MRI and hormonal testing are performed to monitor growth and avoid unnecessary treatment-related risks.
2. Medical therapy
Dopamine agonists reduce prolactin levels and shrink prolactinomas; somatostatin analogs control hormone secretion in growth hormone–secreting adenomas.
3. Minimally invasive endoscopic endonasal transsphenoidal surgery
A mainstream approach that removes the tumor through a natural nasal corridor, with minimal trauma, high precision, and rapid recovery.
4. Craniotomy
For giant tumors or lesions with substantial suprasellar extension, transcranial approaches may be required to address complex anatomy, although they are relatively more invasive.
5. Stereotactic radiosurgery
For postoperative residual or recurrent disease, or for patients who are not surgical candidates, Gamma Knife–based high-precision irradiation can effectively control tumor growth.
6. Stepwise staged treatment
For giant invasive tumors, endoscopic debulking and decompression may be performed first, followed by craniotomy or radiotherapy, to preserve neurological function.
7. Pituitary hormone replacement therapy
If the tumor or treatment results in hypopituitarism, long-term hormone replacement is required to maintain normal metabolism.
8. Multidisciplinary collaborative care
Neurosurgery, endocrinology, and other specialties jointly determine management to ensure individualized and evidence-based treatment strategies.
Jinshazhou Hospital of Guangzhou University of Chinese Medicine emphasizes that although most pituitary adenomas are benign, they can cause substantial impairment of vision, fertility, and other functions. Standardized diagnosis is the first step toward effective management, and early intervention is fundamental to preventing irreversible damage. With MDT-based collaboration and minimally invasive techniques, treatment outcomes can be improved and patients can return to health.